10th Edition Clinical Trials in Canada

$499.00

SKU: PHP10605 Category:

Description

Report Code: PHP10605. June, 2010. Vancouver, BC

ARTICLE I

The Health Research Roadmap: Creating Innovative Research for Better Health and Healthcare in B.C.

Dr. John Challis, DSc, FRCOG, FRSC, PhD
President and Chief Executive Officer
Michael Smith Foundation for Health Research

ARTICLE II

Consortium of Canadian Centres for Cognitive Clinical Research

Dr. B. Lynn Beattie
Secretary Treasurer
Consortium of Canadian Centres for Clinical Cognitive Research (C5R)

ARTICLE III

“Harmonization” and Human Ethics Review in British Columbia

Laurel Evans
Associate Director, Research Ethics
Office of Research Services
University of British Columbia
Past President and Public Affairs Committee
Canadian Association of Research Ethics Boards

ARTICLE IV

What’s Working, What’s Not in a Changing Environment for REBs – National and Regional Initiatives With Regard to Multi-Centre Clinical Trials

Ron Heslegrave, Ph.D.
Chair, Research Ethics Board
University Health Network
Ontario Cancer Research Ethics Board

ARTICLE V

Clinical Trials in Canada: Selected Topics in Research Ethics Review: Case Studies in Tissue Acquisition and Bio-banking

Dr. George Browman
Chair
UBC BCCA Research Ethics Board

ARTICLE VI

Creating and Sustaining Partnerships to Foster Collaboration, Innovation and Growth

Karimah Es Sabar
Senior Vice President, Business and Strategic Affairs
Centre for Drug Research and Development

ARTICLE VII

Regulatory Updates and Issues

Anne Tomalin, BA, BSc, RAC
President
i3 CanReg

ARTICLE VIII

Changes in U.S. Guidelines and Regulations

Ronald Fehst
President
Ronald Fehst Research Consultants

ARTICLE IX

British Columbia Clinical Research Infrastructure Network

Heather Harris-Harper
British Columbia Clinical Research Infrastructure
Network Coordinator, Genome BC

ARTICLE X

Key Issues in Facilitating the Negotiation of CTA’s

Dr. Graeme Boniface
Chief Operating Officer
Vancouver Prostate Centre

ARTICLE XI

Clinical Trial Contracts: Smoothing Out and Speeding Up the Negotiation Process

Donna Mitchell
Director, Saskatchewan Drug Research Institute
University of Saskatchewan

ARTICLE XII

Pharmacokinetic and First-in-Man Studies: Safety in Healthy Volunteers

Dr. Pierre Geoffroy, MD, CM, MSc., F.C.F.P.
Medical Director and Principal Investigator
Biovail Contract Research

ARTICLE XIII

Cost Effective Site Monitoring and Data Management for Greater Web-Enabled Collaboration

Jason Ridderikhoff, B.Sc.N.
Regional Operations Manager, Clinical Research
Eli Lilly Canada Inc.

ARTICLE XIV

Clinical Trial Budgets: Sponsors Perspective

Cheryl Small
Associate Director, Clinical Business Operations
Pfizer Canada Inc.

ARTICLE XV

Clinical Trial Budgets: A Site Perspective

Kate Bailey
Regional Project Planner and Contracts Administrator
Northern Alberta Clinical Trials and Research Centre

ARTICLE XVI

Attracting and Retaining Clinical Trials in Canada

Cheryl Small
Associate Director, Clinical Business Operations
Pfizer Canada Inc.

Krista Nevin
Director, Trial Delivery CV and NS
Acting Scientific Director, CV, GI and RITA
AstraZeneca Canada Inc.